SEC Form 4 · Insider disclosures

Recent Insider Buying

Recent purchases grouped by company. A P-code purchase may be open-market or private; check the filing for context.

Updates delayedUpdated Some disclosures are unavailable

Purchase rows791
Sale rows3,373
Purchase value (USD)US$649.43M
Sale value (USD)US$72.39B

Recent company disclosures

284 companies · 791 rows
APOG

APOGEE ENTERPRISES, INC.

Purchase total ≈ US$2.42K

1 transaction rows · 1 filings

Alvord Christina M

Purchase
Director disclosed purchase of 52 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 0.57%; approximately 9.17K shares afterward

Calculated transaction value approximately US$2.42K
PMN

ProMIS Neurosciences Inc.

Purchase total ≈ US$90.9K

1 transaction rows · 1 filings

Williams Eugene

Purchase
Director disclosed purchase of 26,500 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 193.24%; approximately 40.2K shares afterward

Calculated transaction value approximately US$90.9K
AGMB

AgomAb Therapeutics NV

Purchase total ≈ US$103.5K

3 transaction rows · 1 filings

Epstein David R

Purchase
Director disclosed purchase of 5,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 30K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$34.05K

Epstein David R

Purchase
Director disclosed purchase of 5,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 35K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$34.55K
Show 1 more transaction rows

Epstein David R

Purchase
Director disclosed purchase of 5,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 40K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$34.9K
SYNX

Silynxcom Ltd.

Purchase total ≈ US$39.41K

4 transaction rows · 2 filings

Klein Gal Nir

Purchase
Officer / Director disclosed purchase of 10,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 60.1K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$9.81K

Klein Gal Nir

Purchase
Officer / Director disclosed purchase of 9,940 shares

Filing did not check the 10b5-1 plan indicator

Approximately 70.1K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$9.9K
Show 2 more transaction rows

Klein Nir

Purchase
CEO / Director disclosed purchase of 10,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.81M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$9.81K

Klein Nir

Purchase
CEO / Director disclosed purchase of 9,940 shares

Filing did not check the 10b5-1 plan indicator

Approximately 2.82M shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$9.9K
BCBP

BCB BANCORP INC

Purchase total ≈ US$1K

2 transaction rows · 2 filings

Gallotta Steven E.

Purchase · 4/A
Director disclosed purchase of 55 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 3.76%; approximately 1.51K shares afterward

Calculated transaction value approximately US$502.14

Kim Denny

Purchase · 4/A
Director disclosed purchase of 57 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 3.90%; approximately 1.52K shares afterward

Calculated transaction value approximately US$500.75
GRCE

Grace Therapeutics, Inc.

Purchase total ≈ US$33.02K

3 transaction rows · 1 filings

Opaleye Management Inc.

Purchase
10% owner disclosed purchase of 10,328 shares

Filing did not check the 10b5-1 plan indicator

Approximately 3.05M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$18.48K

Opaleye Management Inc.

Purchase
10% owner disclosed purchase of 5,027 shares

Filing did not check the 10b5-1 plan indicator

Approximately 3.05M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$9.06K
Show 1 more transaction rows

Opaleye Management Inc.

Purchase
10% owner disclosed purchase of 3,087 shares

Filing did not check the 10b5-1 plan indicator

Approximately 3.05M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$5.48K
MTUS

Metallus Inc.

Purchase total ≈ US$166.1K

1 transaction rows · 1 filings

RICE RONALD A

Purchase
Director disclosed purchase of 10,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 6.58%; approximately 162K shares afterward

Calculated transaction value approximately US$166.1K
TRAD

APEX Tech Acquisition Inc.

Purchase total unavailable

2 transaction rows · 2 filings

2 rows excluded from USD total

Liu Shaoren / APEX INNOVATION ACQUISITION CORP.

Purchase
CEO / CFO / Director / 10% owner disclosed purchase of 3,029 shares

Filing did not check the 10b5-1 plan indicator

Approximately 3.09M shares in indirect holdings afterward; change percentage not reliably calculable

Transaction value pending verification

Liu Shaoren / APEX INNOVATION ACQUISITION CORP.

Purchase
CEO / CFO / Director / 10% owner disclosed purchase of 208,971 shares

Filing did not check the 10b5-1 plan indicator

Approximately 3.08M shares in indirect holdings afterward; change percentage not reliably calculable

Transaction value pending verification
NONE

Third Point Private Capital Income Fund

Purchase total ≈ US$4M

1 transaction rows · 1 filings

Loeb Daniel S / Third Point LLC / Third Point Private Capital LLC

Purchase
10% owner disclosed purchase of 160,000 shares

Filing did not check the 10b5-1 plan indicator

Approximately 161K shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$4M
NONE

Third Point Private Capital Partners

Purchase total ≈ US$9.69M

2 transaction rows · 1 filings

Loeb Daniel S / Third Point LLC / Third Point Private Capital LLC

Purchase
10% owner disclosed purchase of 46,242.77 shares

Filing did not check the 10b5-1 plan indicator

Approximately 1.65M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$2M

Loeb Daniel S / Third Point LLC / Third Point Private Capital LLC

Purchase
10% owner disclosed purchase of 285,916.87 shares

Filing did not check the 10b5-1 plan indicator

Approximately 1.93M shares in indirect holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$7.69M
BXMT

BLACKSTONE MORTGAGE TRUST, INC.

Purchase total ≈ US$1.15M

2 transaction rows · 2 filings

NASSAU HENRY N

Purchase
Director disclosed purchase of 10,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 4.47%; approximately 233K shares afterward

Calculated transaction value approximately US$114.29K

Johnson Timothy Steven

Purchase
CEO / Director disclosed purchase of 90,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 17.04%; approximately 618K shares afterward

Calculated transaction value approximately US$1.04M
LAB

STANDARD BIOTOOLS INC.

Purchase total ≈ US$46.9K

1 transaction rows · 1 filings

Carey Thomas D.

Purchase
Director disclosed purchase of 75,000 shares

Filing did not check the 10b5-1 plan indicator

Purchase increased prior direct holdings by approximately 21.77%; approximately 419K shares afterward

Calculated transaction value approximately US$46.9K
Sources, coverage & updates
SEC filing dates: 2026-11-04 — 2026-11-13 (America/New_York)

Current-day data is provisional; historical dates are reconciled to official daily indexes.

Last successful sync: Nov 11, 7:34 PM ET

Partial coverage; backfill in progress

Discovered filings 3,950 · Parsed 3,950 · Pending 0

Table I non-derivative P/S only. Values use reported price × shares; 95 unavailable, unverified or non-USD amounts are excluded. 1836 filings · 1788 distinct reporting owners, not necessarily independent decision-makers.

Company grouping is a reading aid, not a merger of transactions or uncertain ownership ratios. Value sorting uses each company’s usable total; expand to see every matching row.

Reading these disclosures

Form 4 disclosures are not real-time trade alerts. An unchecked 10b5-1 indicator does not establish discretionary timing. Direct and indirect holdings remain separate; unresolved amendments stay under review.

Filed prices are not all independently market-verified. Source: SEC EDGAR; the update target is every 15 minutes. Actual freshness is shown by the last successful synchronization.

SEC transaction codes ↗